Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat

Psychopharmacology

Volumn 144, Issue 1, 1999, Pages 67-76

  Marston, Hugh M ^a   Reid, Morag E ^a   Lawrence, Jane A ^a   Olverman, Henry J ^a   Butcher, Steven P ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Citalopram binding; Cognition; DNMTP; Locomotor activity; MDMA; Neurotoxicity; Paw reaching; Temperature 5 HT

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CITALOPRAM; NEUROTOXIN;

ANALYTIC METHOD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; LONG TERM EXPOSURE; MOTOR PERFORMANCE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; TEMPERATURE;

ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITALOPRAM; KINETICS; MALE; MENTAL DISORDERS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RADIOLIGAND ASSAY; RATS;

EID: 0032976911     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050978     Document Type: Article

References (41)

1. Altman HJ, Normile HJ (1988) What is the nature of the role of the serotonergic nervous system in learning and memory: prospects for development of an effective treatment strategy for senile dementia. Neurobiol Ageing 9:627-638
2. Battaglia G, Yeh SY, De Souza EB (1987a) MDMA induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurones. Pharmacol Biochem Behav 29:269-274
3. 3H] paroxitine-labelled serotonin uptake sites. J Pharmacol Exp Ther 242:911-916
4. Colado MI, Williams JL, Green AR (1995) The hyperthermic and neurotoxic effects of "Ecstasy" (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Br J Pharmacol 115:1281-1289
5. Dafters RI (1994) Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats. Psychopharmacology 114:505-508
6. Dafters RI (1995) Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Physiol Behav 58:877-882
7. Dafters RI, Lynch E (1998) Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology 138:207-212
8. Fischer C, Hatzidimitriou G, Wlos G, Katz J, Ricaurte G (1995) Reorganisation of ascending 5-HT axon projections in animals previously exposed to the recreational drug (±)-3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). J Neurosci 15:5476-5485
9. Frederick DL, Gillam MP, Allen RR, Paule MG (1995a) Acute effects of methylenedioxymethamphetamine (MDMA) on several complex brain functions in monkeys. Pharmacol Biochem Behav 51:301-307
10. Frederick DL, Ali SF, Slikker W Jr, Gillam MP, Allen RR, Paule MG (1995b) Behavioural and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in Rhesus monkeys. Neurotoxicol Teratol 17:531-543
11. Hiramatasu MT, Kameyama NT, Meada Y, Cho K (1988) The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behaviours in the rat. Pharmacol Biochem Behav 33:343-347
12. Jacobs BL (1976) An animal model for studying central serotonergic synapses. Life Sci 19:777-786
13. 1A and 5-HT transporter binding sites in rat cortex and hippocampus following cholinergic and serotonergic lesions. Brain Res 612:326-329
14. LeSage M, Clark R, Poling A (1993) MDMA and memory: the acute and chronic effects of MDMA in pigeons performing under a delayed-matching-to-sample procedure. Psychopharmacology 110:327-332
15. Malberg JE, Seiden LS (1998) Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature. J Neurosci 18:5086-5094
16. Marston HM, Faber ESL, Crawford JH, Butcher SP, Sharkey JS (1995) Behavioural assessment of endothelin-1 induced middle cerebral artery occlusion in the rat. Neuroreport 6: 1067-1071
17. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomography evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurones in human beings. Lancet 352:1433-1437
18. McDowell DM, Kleber HD (1994) MDMA: its history and pharmacology. Psychiatr Ann 24:127-130
19. McNamara MG, Kelly JP, Leonard BE (1995) Some behavioural and neurochemical aspects of subacute (±)-3,4-methylenedioxymethamphetamine administration in rats. Pharmacol Biochem Behav 52:479-484
20. Molliver ME, Berger UV, Mamounas LA, Molliver DC, Wilson MA (1990) Neurotoxicity of MDMA and related compounds: anatomic studies. Ann NY Acad Sci 600:682-698
21. Nash JF, Brodkin J (1991) Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors. J Pharmacol Exp Ther 259: 820-825
22. Nash JF, Meltzer HY, Gudelsky GA (1988) Elevation of serum prolactin and corticosterone concentrations in the rat after administration of 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 245:373-379
23. Parrott AC (1998) Emotional and cognitive effects of MDMA ("ecstasy"): the psychological perspective. J Psychopharmacol 12:99-100
24. Parrott AC, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after Saturday night dance. Psychopharmacology 139:261-268
25. Paulus MP, Geyer MA (1992) The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity. Neuropsychopharmacology 7:15-31
26. Peroutka SJ (1987) Incidence of recreational use of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") on an undergraduate campus. N Engl J Med 317:1542-1543
27. Randall T (1992) Ecstasy-fuelled "rave" parties become dances of death for English youths. JAMA 268:1505-1506
28. Ricaurte GA, Martello AL, Katz JL, Martello MB (1992) Lasting effects of (±)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurones in non-human primates: neurochemical observations. J Pharmacol Exp Ther 261:616-622
29. Ricaurte GA, Markowska AL, Wenk GA, Hazidimitriou G, Wlos J, Olton DS (1993) 3,4-Methylenedioxymethamphetamine, serotonin and memory. J Pharmacol Exp Ther 266:1097-1105
30. Sahgal A (1987) Some limitations of indices derived from signal detection theory: evaluation of an alternative index for measuring bias in memory tasks. Psychopharmacology 91:517-520
31. Scanzello CR, Hatzidimitriou G, Martello M, Katz J, Ricaurte GA (1993) Serotonergic recovery after (±)-3,4-methylenedioxymethamphetamine injury: observations in rats. J Pharmacol Exp Ther 264:1484-1491
32. Scheffel U, Szabo Z, Mathews WB, Finley PA, Dannals RF, Ravert HT, Szabo K, Yuan J, Ricaurte GA (1998) In vivo detection of short- and long-term MDMA neurotoxicity: a positron emission tomography study in the living baboon brain Synapse 29:183-192
33. Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxyamphetamine. J Pharmacol Exp Ther 240:1-7
34. Schmidt CJ, Levin AL and Lovenberg W (1986) In vitro and in vivo neurochemical effects of methylenedioxyamphetamine on striatal monoaminergic systems in the brain. Biochem Pharmacol 36:747-755
35. Sharkey J, McBean DE, Kelly PAT (1991) Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy"). Psychopharmacology 105:113-118
36. Solivier RS, Drust EG, Conner JD (1978) Specificity of a rat behavioural model for serotonin receptor activation. J Pharmacol Exp Ther 206:339-347
37. Sprague JE, Everman SL, Nichols DE (1998) An integrated hypothesis for the serotonergic loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology 19:427-441
38. Stone DM, Stahl DC, Hanson GR, Gibb JW (1986) The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the brain. Eur J Pharmacol 128:41-48
39. Stone DM, Merchant KM, Hanson GR, Gibb JW (1987) Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology 26:1677-1683
40. Vanderwolf CH (1987) Suppression of serotonin-dependent cerebral activation: a possible mechanism of action of some psychotomimetic drugs. Brain Res 414:109-118
41. Yamamoto BK, Spanos LJ (1989) The acute effects of methylenedioxyamphetamine on dopamine release in the awake behaving rat. Eur J Pharmacol 148:195-203